我们应该使用哪个数据分析工具来评估药品供应链上游的风险?
Matt Christian1, Wejdan Bagais2
1Director of supply chain insights at US Pharmacopeia.
AMA journal of ethics
|April 2, 2024
概括
美国的药物短缺影响了患者的护理和费用. 这项研究确定了病因,并为稳定的药物供应提出了创新建议.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 供应链管理 供应链管理
背景情况:
- 药物短缺对美国的患者护理和医疗保健支出构成重大挑战.
- 导致这些短缺的因素是多方面的,影响到必需药物的可获得性.
研究的目的:
- 确定导致美国药物短缺的关键因素.
- 提出创新解决方案,包括早期预警系统和修订的支付,合同和定价策略.
- 为利益相关者提供数据驱动的建议,以确保可靠的优质药品供应.
主要方法:
- 分析导致药物短缺的因素,包括制造复杂性,定价动态和质量检查数据.
- 对潜在的药物短缺进行概念早期预警系统的开发.
- 检查支付,合同和定价模式,以减轻短缺风险.
主要成果:
- 制造复杂性,定价和质量检查记录被确定为药物短缺的重要贡献者.
- 提出了一个早期预警系统框架,以主动识别有风险的药物.
- 创新的支付,合同和定价策略显示出稳定药物供应链的潜力.
结论:
- 解决药物短缺问题需要采取多方面的方法,涉及制造商,政策制定者和医疗保健提供者.
- 实施早期预警系统和创新的经济模式可以提高制药供应链的弹性.
- 积极主动的,数据驱动的策略对于保障优质药品的可用性至关重要.
相关概念视频
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62


